Skip to main content
editor@theusajournals.com | Oscar Publishing Services Journal Home
Login

International Journal of Medical Sciences And Clinical Research

Peer Reviewed | Open Access | E-ISSN: 2771-2265
Published Article

Assessment of Heart Rate Variability with COPD Associated with Pulmonary and Arterial Hypertension

Assessment of Heart Rate Variability with COPD Associated with Pulmonary and Arterial Hypertension

Authors

  • Daminov B.T.
    Department of Internal Medicine, nephrology and hemodialysis, Tashkent State Medical University, Tashkent, Uzbekistan
  • Shamukhamedova N.Sh.
    Department of Internal Medicine, nephrology and hemodialysis, Tashkent State Medical University, Tashkent, Uzbekistan
  • Kadirova G.G.
    Department of Internal Medicine, nephrology and hemodialysis, Tashkent State Medical University, Tashkent, Uzbekistan
  • Abrorova B.T.
    Department of Internal Medicine, nephrology and hemodialysis, Tashkent State Medical University, Tashkent, Uzbekistan

DOI:

https://doi.org/10.37547/ijmscr/Volume06Issue04-14

Keywords:

Chronic obstructive pulmonary disease arterial hypertension pulmonary hypertension

Abstract

The work analyzed the heart rate variability of patients with chronic obstructive pulmonary disease with arterial and pulmonary hypertension. The degree of COPD and the determination of disease stages were carried out according to the GOLD recommendations (2011–2019), the severity of dyspnea was assessed using the Modified Medical Research Council Dyspnea Scale (mMRC). The study of heart rate variability (HRV) was carried out using a computer complex with registration of a five-minute ECG recording, with interpretation of the results of temporal and spectral analysis of HRV based on the recommendations of the European Society of Cardiology and the North American Society of Cardiopacing and Electrophysiology (ESC/NASPE, 1996).

References

Avdeev, S. N. (2015). Pulmonary hypertension associated with lung diseases. In I. E. Chasova & T. V. Martynyuk (Eds.), Pulmonary hypertension (pp. 525–562). Moscow, Russia: Praktika.

Global Initiative for Chronic Obstructive Lung Disease. (2017). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2017 report). Retrieved from https://www.goldcopd.com

Zangiabadi, A., De Pasquale, C. G., & Sajkov, D. (2014). Pulmonary hypertension and right heart dysfunction in chronic lung disease. BioMed Research International, 2014, Article ID (if available). https://doi.org/ (add DOI if known)

Shpagin, I. S., Kotova, O. S., Pospelova, T. I., Gerasimenko, O. N., Shpagina, L. A., & Ermakova, M. A. (2016). Chronic obstructive pulmonary disease in combination with essential arterial hypertension: Clinical, functional and molecular genetic features. Bulletin of Modern Clinical Medicine, 9(4), 56–65.

Chazova, I. E., Chuchalin, A. G., Zykov, K. A., et al. (2013). Diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease. Systemic Hypertension, 10, 5–34.

Ovcharenko, S. I., Nersesyan, Z. N., & Morozova, T. E. (2015). COPD combined with arterial hypertension: Assessment of systemic inflammation and endothelial dysfunction. Pulmonology, 25(5), 561–565.